Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 2 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 8563512

    Neprilysin inhibitors

    Theravance, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  2. US 8557997

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  3. US 8557978

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  4. US 8551978

    Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity

    Theravance, Inc. · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  5. US 8541597

    Process for preparing biphenyl imidazole compounds

    Theravance, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  6. US 8541451

    Crystalline freebase forms of a biphenyl compound

    Theravance, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  7. US 8541375

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted

  8. US 8536335

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance, Inc. · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  9. US 8530663

    1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds

    Theravance, Inc. · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  10. US 8518966

    Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  11. US 8513432

    Dual-acting benzoimidazole antihypertensive agents

    Theravance, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  12. US 8513244

    Neprilysin inhibitors

    Theravance, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  13. US 8501776

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  14. US 8501798

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  15. US 8501964

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  16. US 8497287

    Aminotetralin compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  17. US 8492407

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  18. US 8492399

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  19. US 8487107

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  20. US 8486958

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance, Inc. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  21. US 8481549

    Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents

    Theravance, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  22. US 8481044

    Neprilysin inhibitors

    Theravance, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  23. US 8481563

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  24. US 8476299

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.